Texas, Houston -- (SBWIRE) -- 02/04/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Palatin Technologies, Inc. (NYSE:PTN) added 0.27% and is trading at $0.600. Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company engaged in the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.
Can PTN Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Rexahn Pharmaceuticals, Inc. (NYSE:RNN) is higher 9.58% and is trading at $0.362. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials.
How Should Investors Trade RNN After The Recent Volatile Moves? Find Out Here
A.P. Pharma, Inc. (OTC:APPA) is higher 3.87% and is trading at $0.805. A.P. Pharma, Inc. operates as pharmaceutical company focused on the development and commercialization of medical treatments utilizing its Biochronomer, a polymer-based drug delivery technology. The Company's focus is on its lead product candidate, APF530, which aims to prevent chemotherapy-induced nausea and vomiting (CINV).
Is APPA Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
BioFuel Energy Corp. (NASDAQ:BIOF) is higher 3.56% and is trading at $4.94. BioFuel Energy Corp. is a holding company. The Company produces and sells ethanol and its co-products (primarily distillers grain and corn oil), through its two ethanol production facilities located in Wood River, Nebraska and Fairmont, Minnesota.
Can BIOF Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
ADVENTRX Pharmaceuticals, Inc. (NYSE:ANX) is higher 2.70% and is trading at $0.760. ADVENTRX Pharmaceuticals, Inc. Operates as a biopharmaceutical research and development company. The Company's business strategy is to commercialize leading edge medical research through licensing agreements with prominent universities and research institutions.
Is ANX Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)